Amneal Pharmaceuticals, Inc. (AMRX)
12.21
-0.04
(-0.33%)
USD |
NASDAQ |
Dec 12, 16:00
12.20
-0.01
(-0.08%)
After-Hours: 20:00
Amneal Pharmaceuticals Free Cash Flow: 236.43M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| AbbVie, Inc. | 19.68B |
| Johnson & Johnson | 20.46B |
| Amgen, Inc. | 11.54B |
| United Therapeutics Corp. | 1.116B |
| Xeris Biopharma Holdings, Inc. | 9.975M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 118.45M |
| Cash from Investing (Quarterly) | -22.46M |
| Cash from Financing (Quarterly) | 59.44M |
| Free Cash Flow Per Share (Quarterly) | 0.2956 |
| Free Cash Flow to Equity (Quarterly) | -7.845M |
| Free Cash Flow to Firm (Quarterly) | -122.08M |
| Free Cash Flow Yield | 6.05% |